世界のバイオシミラー試験・開発サービス市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0846 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、バイオシミラー試験・開発サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エフェクター結合、ELISA、キネティック結合アッセイ、ADCC・CDC細胞ベースアッセイ）、用途別市場規模（PKアッセイ、階層型免疫原性試験、NAbアッセイ）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・バイオシミラー試験・開発サービスの市場動向 ・企業の競争状況、市場シェア ・バイオシミラー試験・開発サービスの種類別市場規模（エフェクター結合、ELISA、キネティック結合アッセイ、ADCC・CDC細胞ベースアッセイ） ・バイオシミラー試験・開発サービスの用途別市場規模（PKアッセイ、階層型免疫原性試験、NAbアッセイ） ・バイオシミラー試験・開発サービスの北米市場規模2016-2027（アメリカ、カナダ） ・バイオシミラー試験・開発サービスのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・バイオシミラー試験・開発サービスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バイオシミラー試験・開発サービスの中南米市場規模2016-2027（メキシコ、ブラジル） ・バイオシミラー試験・開発サービスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eurofins Scientific、SGS、Charles River Laboratories、Pharmaceutical Product Development、Exova、Source BioScience、Intertek Group、Medistri、Pace Analytical Services、Sigma-Aldrich） ・結論

The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified into effector binding, ELISA, kinetic binding assays, and ADCC & CDC cell-based assays.

Market Analysis and Insights: Global Biosimilar Testing and Development Services Market
The global Biosimilar Testing and Development Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biosimilar Testing and Development Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biosimilar Testing and Development Services market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biosimilar Testing and Development Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biosimilar Testing and Development Services market.

Global Biosimilar Testing and Development Services Scope and Market Size
Biosimilar Testing and Development Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Testing and Development Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays

Segment by Application
PK assay
Tiered Immunogenicity testing
NAb assays

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Effector Binding
1.2.3 ELISA
1.2.4 Kinetic Binding Assays
1.2.5 ADCC & CDC Cell-Based Assays
1.3 Market by Application
1.3.1 Global Biosimilar Testing and Development Services Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biosimilar Testing and Development Services Market Perspective (2016-2027)
2.2 Biosimilar Testing and Development Services Growth Trends by Regions
2.2.1 Biosimilar Testing and Development Services Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biosimilar Testing and Development Services Historic Market Share by Regions (2016-2021)
2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Regions (2022-2027)
2.3 Biosimilar Testing and Development Services Industry Dynamic
2.3.1 Biosimilar Testing and Development Services Market Trends
2.3.2 Biosimilar Testing and Development Services Market Drivers
2.3.3 Biosimilar Testing and Development Services Market Challenges
2.3.4 Biosimilar Testing and Development Services Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing and Development Services Players by Revenue
3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2016-2021)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2016-2021)
3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2020
3.5 Biosimilar Testing and Development Services Key Players Head office and Area Served
3.6 Key Players Biosimilar Testing and Development Services Product Solution and Service
3.7 Date of Enter into Biosimilar Testing and Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar Testing and Development Services Breakdown Data by Type
4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2016-2021)
4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2022-2027)

5 Biosimilar Testing and Development Services Breakdown Data by Application
5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2016-2021)
5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biosimilar Testing and Development Services Market Size (2016-2027)
6.2 North America Biosimilar Testing and Development Services Market Size by Type
6.2.1 North America Biosimilar Testing and Development Services Market Size by Type (2016-2021)
6.2.2 North America Biosimilar Testing and Development Services Market Size by Type (2022-2027)
6.2.3 North America Biosimilar Testing and Development Services Market Size by Type (2016-2027)
6.3 North America Biosimilar Testing and Development Services Market Size by Application
6.3.1 North America Biosimilar Testing and Development Services Market Size by Application (2016-2021)
6.3.2 North America Biosimilar Testing and Development Services Market Size by Application (2022-2027)
6.3.3 North America Biosimilar Testing and Development Services Market Size by Application (2016-2027)
6.4 North America Biosimilar Testing and Development Services Market Size by Country
6.4.1 North America Biosimilar Testing and Development Services Market Size by Country (2016-2021)
6.4.2 North America Biosimilar Testing and Development Services Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Biosimilar Testing and Development Services Market Size (2016-2027)
7.2 Europe Biosimilar Testing and Development Services Market Size by Type
7.2.1 Europe Biosimilar Testing and Development Services Market Size by Type (2016-2021)
7.2.2 Europe Biosimilar Testing and Development Services Market Size by Type (2022-2027)
7.2.3 Europe Biosimilar Testing and Development Services Market Size by Type (2016-2027)
7.3 Europe Biosimilar Testing and Development Services Market Size by Application
7.3.1 Europe Biosimilar Testing and Development Services Market Size by Application (2016-2021)
7.3.2 Europe Biosimilar Testing and Development Services Market Size by Application (2022-2027)
7.3.3 Europe Biosimilar Testing and Development Services Market Size by Application (2016-2027)
7.4 Europe Biosimilar Testing and Development Services Market Size by Country
7.4.1 Europe Biosimilar Testing and Development Services Market Size by Country (2016-2021)
7.4.2 Europe Biosimilar Testing and Development Services Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Testing and Development Services Market Size (2016-2027)
8.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type
8.2.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2016-2027)
8.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application
8.3.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2016-2027)
8.4 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region
8.4.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biosimilar Testing and Development Services Market Size (2016-2027)
9.2 Latin America Biosimilar Testing and Development Services Market Size by Type
9.2.1 Latin America Biosimilar Testing and Development Services Market Size by Type (2016-2021)
9.2.2 Latin America Biosimilar Testing and Development Services Market Size by Type (2022-2027)
9.2.3 Latin America Biosimilar Testing and Development Services Market Size by Type (2016-2027)
9.3 Latin America Biosimilar Testing and Development Services Market Size by Application
9.3.1 Latin America Biosimilar Testing and Development Services Market Size by Application (2016-2021)
9.3.2 Latin America Biosimilar Testing and Development Services Market Size by Application (2022-2027)
9.3.3 Latin America Biosimilar Testing and Development Services Market Size by Application (2016-2027)
9.4 Latin America Biosimilar Testing and Development Services Market Size by Country
9.4.1 Latin America Biosimilar Testing and Development Services Market Size by Country (2016-2021)
9.4.2 Latin America Biosimilar Testing and Development Services Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Testing and Development Services Market Size (2016-2027)
10.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type
10.2.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2016-2027)
10.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application
10.3.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2016-2027)
10.4 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country
10.4.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.1.5 Eurofins Scientific Recent Development
11.2 SGS
11.2.1 SGS Company Details
11.2.2 SGS Business Overview
11.2.3 SGS Biosimilar Testing and Development Services Introduction
11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.2.5 SGS Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.3.5 Charles River Laboratories Recent Development
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Details
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.4.5 Pharmaceutical Product Development Recent Development
11.5 Exova
11.5.1 Exova Company Details
11.5.2 Exova Business Overview
11.5.3 Exova Biosimilar Testing and Development Services Introduction
11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.5.5 Exova Recent Development
11.6 Source BioScience
11.6.1 Source BioScience Company Details
11.6.2 Source BioScience Business Overview
11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.6.5 Source BioScience Recent Development
11.7 Intertek Group
11.7.1 Intertek Group Company Details
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.7.5 Intertek Group Recent Development
11.8 Medistri
11.8.1 Medistri Company Details
11.8.2 Medistri Business Overview
11.8.3 Medistri Biosimilar Testing and Development Services Introduction
11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.8.5 Medistri Recent Development
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Details
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.9.5 Pace Analytical Services Recent Development
11.10 Sigma-Aldrich
11.10.1 Sigma-Aldrich Company Details
11.10.2 Sigma-Aldrich Business Overview
11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2016-2021)
11.10.5 Sigma-Aldrich Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Effector Binding
Table 3. Key Players of ELISA
Table 4. Key Players of Kinetic Binding Assays
Table 5. Key Players of ADCC & CDC Cell-Based Assays
Table 6. Global Biosimilar Testing and Development Services Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Biosimilar Testing and Development Services Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Biosimilar Testing and Development Services Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Biosimilar Testing and Development Services Market Share by Regions (2016-2021)
Table 10. Global Biosimilar Testing and Development Services Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Biosimilar Testing and Development Services Market Share by Regions (2022-2027)
Table 12. Biosimilar Testing and Development Services Market Trends
Table 13. Biosimilar Testing and Development Services Market Drivers
Table 14. Biosimilar Testing and Development Services Market Challenges
Table 15. Biosimilar Testing and Development Services Market Restraints
Table 16. Global Biosimilar Testing and Development Services Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Biosimilar Testing and Development Services Market Share by Players (2016-2021)
Table 18. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing and Development Services as of 2020)
Table 19. Ranking of Global Top Biosimilar Testing and Development Services Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Biosimilar Testing and Development Services Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Biosimilar Testing and Development Services Product Solution and Service
Table 23. Date of Enter into Biosimilar Testing and Development Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2016-2021)
Table 27. Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Biosimilar Testing and Development Services Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2016-2021)
Table 31. Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eurofins Scientific Company Details
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Biosimilar Testing and Development Services Product
Table 66. Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 67. Eurofins Scientific Recent Development
Table 68. SGS Company Details
Table 69. SGS Business Overview
Table 70. SGS Biosimilar Testing and Development Services Product
Table 71. SGS Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 72. SGS Recent Development
Table 73. Charles River Laboratories Company Details
Table 74. Charles River Laboratories Business Overview
Table 75. Charles River Laboratories Biosimilar Testing and Development Services Product
Table 76. Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 77. Charles River Laboratories Recent Development
Table 78. Pharmaceutical Product Development Company Details
Table 79. Pharmaceutical Product Development Business Overview
Table 80. Pharmaceutical Product Development Biosimilar Testing and Development Services Product
Table 81. Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 82. Pharmaceutical Product Development Recent Development
Table 83. Exova Company Details
Table 84. Exova Business Overview
Table 85. Exova Biosimilar Testing and Development Services Product
Table 86. Exova Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 87. Exova Recent Development
Table 88. Source BioScience Company Details
Table 89. Source BioScience Business Overview
Table 90. Source BioScience Biosimilar Testing and Development Services Product
Table 91. Source BioScience Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 92. Source BioScience Recent Development
Table 93. Intertek Group Company Details
Table 94. Intertek Group Business Overview
Table 95. Intertek Group Biosimilar Testing and Development Services Product
Table 96. Intertek Group Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 97. Intertek Group Recent Development
Table 98. Medistri Company Details
Table 99. Medistri Business Overview
Table 100. Medistri Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 101. Medistri Recent Development
Table 102. Pace Analytical Services Company Details
Table 103. Pace Analytical Services Business Overview
Table 104. Pace Analytical Services Biosimilar Testing and Development Services Product
Table 105. Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 106. Pace Analytical Services Recent Development
Table 107. Sigma-Aldrich Company Details
Table 108. Sigma-Aldrich Business Overview
Table 109. Sigma-Aldrich Biosimilar Testing and Development Services Product
Table 110. Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
Table 111. Sigma-Aldrich Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar Testing and Development Services Market Share by Type: 2020 VS 2027
Figure 2. Effector Binding Features
Figure 3. ELISA Features
Figure 4. Kinetic Binding Assays Features
Figure 5. ADCC & CDC Cell-Based Assays Features
Figure 6. Global Biosimilar Testing and Development Services Market Share by Application: 2020 VS 2027
Figure 7. PK assay Case Studies
Figure 8. Tiered Immunogenicity testing Case Studies
Figure 9. NAb assays Case Studies
Figure 10. Biosimilar Testing and Development Services Report Years Considered
Figure 11. Global Biosimilar Testing and Development Services Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Biosimilar Testing and Development Services Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Biosimilar Testing and Development Services Market Share by Regions: 2020 VS 2027
Figure 14. Global Biosimilar Testing and Development Services Market Share by Regions (2022-2027)
Figure 15. Global Biosimilar Testing and Development Services Market Share by Players in 2020
Figure 16. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing and Development Services as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2020
Figure 18. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2016-2021)
Figure 19. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2022-2027)
Figure 20. North America Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Biosimilar Testing and Development Services Market Share by Type (2016-2027)
Figure 22. North America Biosimilar Testing and Development Services Market Share by Application (2016-2027)
Figure 23. North America Biosimilar Testing and Development Services Market Share by Country (2016-2027)
Figure 24. United States Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Biosimilar Testing and Development Services Market Share by Type (2016-2027)
Figure 28. Europe Biosimilar Testing and Development Services Market Share by Application (2016-2027)
Figure 29. Europe Biosimilar Testing and Development Services Market Share by Country (2016-2027)
Figure 30. Germany Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Biosimilar Testing and Development Services Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Biosimilar Testing and Development Services Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Biosimilar Testing and Development Services Market Share by Region (2016-2027)
Figure 40. China Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Biosimilar Testing and Development Services Market Share by Type (2016-2027)
Figure 48. Latin America Biosimilar Testing and Development Services Market Share by Application (2016-2027)
Figure 49. Latin America Biosimilar Testing and Development Services Market Share by Country (2016-2027)
Figure 50. Mexico Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Biosimilar Testing and Development Services Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Biosimilar Testing and Development Services Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Biosimilar Testing and Development Services Market Share by Country (2016-2027)
Figure 56. Turkey Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 60. SGS Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 61. Charles River Laboratories Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 62. Pharmaceutical Product Development Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 63. Exova Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 64. Source BioScience Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 65. Intertek Group Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 66. Medistri Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 67. Pace Analytical Services Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 68. Sigma-Aldrich Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---